NEUROPHTH Trademark

Trademark Overview


On Friday, April 22, 2022, a trademark application was filed for NEUROPHTH with the United States Patent and Trademark Office. The USPTO has given the NEUROPHTH trademark a serial number of 97376515. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 23, 2024. This trademark is owned by Wuhan Neurophth Biotechnology Limited Company. The NEUROPHTH trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceuticals for treatment of eye diseases; Pharmaceutical preparations for injection for post op care of cataract surgery; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists ophthalmic anti-infective substances for the treatment of infections; Pharmaceutical preparations, namely, ophthalmic preparations; Medicines for human purposes, for the treatment of injury of optic nerve
neurophth

General Information


Serial Number97376515
Word MarkNEUROPHTH
Filing DateFriday, April 22, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "Neurophth" above three Chinese Characters, with the left side of the letter "O" replaced by a DNA double helix design.
NOT AVAILABLEThe non-Latin characters in the mark transliterate to "Niu", "Fu", "Si" and this means "Tie", "Blessing", "This" in English.
Goods and ServicesInjectable pharmaceuticals for treatment of eye diseases; Pharmaceutical preparations for injection for post op care of cataract surgery; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists ophthalmic anti-infective substances for the treatment of infections; Pharmaceutical preparations, namely, ophthalmic preparations; Medicines for human purposes, for the treatment of injury of optic nerve
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWuhan Neurophth Biotechnology Limited Company
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressWuhan City, Hubei 430075
CN

Party NameWuhan Neurophth Biotechnology Limited Company
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWuhan City, Hubei 430075
CN

Trademark Events


Event DateEvent Description
Tuesday, April 26, 2022NEW APPLICATION ENTERED
Wednesday, April 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 28, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 9, 2023ASSIGNED TO EXAMINER
Monday, February 13, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, February 13, 2023EXAMINERS AMENDMENT E-MAILED
Monday, February 13, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 13, 2023EXAMINER'S AMENDMENT ENTERED
Monday, February 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 20, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 20, 2023SOU EXTENSION 1 FILED
Thursday, July 20, 2023SOU EXTENSION 1 GRANTED
Saturday, July 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 12, 2024SOU EXTENSION 2 GRANTED
Friday, April 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 12, 2024SOU EXTENSION 2 FILED
Saturday, April 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 23, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 23, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED